Developments in pharmacotherapy for tobacco dependence: past, present and future
作者： JONATHAN FOULDS , MICHAEL B. STEINBERG , JILL M. WILLIAMS , DOUGLAS M. ZIEDONIS
DOI: 10.1080/09595230500459529
关键词: Rimonabant 、 Varenicline 、 Smoking cessation 、 Medicine 、 Nicotine 、 Pharmacotherapy 、 Bupropion 、 Nicotine gum 、 Psychiatry 、 Inhaler
摘要: In the mid-1970s there were no effective pharmacological treatments for tobacco dependence. The invention of nicotine gum was a major treatment advance and also greatly helped our understanding nature There are now eight pharmacotherapies (nicotine gum, patch, nasal spray, inhaler, lozenge/tablet, bupropion, nortriptyline clonidine) available to aid smoking cessation. Other non-nicotine agents that show promise under investigation, including glucose, rimonabant, selegiline varenicline. Greater knowledge mechanisms action should lead better Future research into optimal examine long-term combination pharmacotherapy combined with improved psychosocial support is partly designed enhance medication compliance. addition, need studies evaluate efficacy in populations such as youth, ...
core.ac.uk
elsevier.com
sci-hub.se 参考文章(98)
Joseph McEvoy, Oliver Freudenreich, Mark McGee, Carol Vanderzwaag, Edward Levin, Jed Rose, Clozapine decreases smoking in patients with chronic schizophrenia Biological Psychiatry. ,vol. 37, pp. 550- 552 ,(1995) , 10.1016/0006-3223(94)00365-A
Luc F Van Gaal, Aila M Rissanen, André J Scheen, Olivier Ziegler, Stephan Rössner, None, Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study The Lancet. ,vol. 365, pp. 1389- 1397 ,(2005) , 10.1016/S0140-6736(05)66374-X
Suchitra Krishnan-Sarin, Boris Meandzija, Stephanie O'Malley, Naltrexone and nicotine patch in smoking cessation: A preliminary study Nicotine & Tobacco Research. ,vol. 5, pp. 851- 857 ,(2003) , 10.1080/14622200310001614601
ANDREW J. BAILLIE, RICHARD P. MATTICK, WAYNE HALL, PAM WEBSTER, Meta-analytic review of the efficacy of smoking cessation interventions. Drug and Alcohol Review. ,vol. 13, pp. 157- 170 ,(1994) , 10.1080/09595239400185231
Robert West, Peter Hajek, Fredrik Nilsson, Jonathan Foulds, Sylvia May, Anna Meadows, Individual differences in preferences for and responses to four nicotine replacement products. Psychopharmacology. ,vol. 153, pp. 225- 230 ,(2001) , 10.1007/S002130000577
C COHEN, E KODAS, G GRIEBEL, CB1 receptor antagonists for the treatment of nicotine addiction. Pharmacology, Biochemistry and Behavior. ,vol. 81, pp. 387- 395 ,(2005) , 10.1016/J.PBB.2005.01.024
Ivan Berlin, Sophie Saïd, Odile Spreux-Varoquaux, Jean-Marie Launay, Robert Olivares, Véronique Millet, Yves Lecrubier, Alain J. Puech, A reversible monoamine oxidase A inhibitor (moclobemide) facilitates smoking cessation and abstinence in heavy, dependent smokers Clinical Pharmacology & Therapeutics. ,vol. 58, pp. 444- 452 ,(1995) , 10.1016/0009-9236(95)90058-6
Mats Wallström, Fredrik Nilsson, Jan-M. Hirsch, A randomized, double‐blind, placebo‐controlled clinical evaluation of a nicotine sublingual tablet in smoking cessation Addiction. ,vol. 95, pp. 1161- 1171 ,(2000) , 10.1046/J.1360-0443.2000.95811613.X
Caryn Lerman, Vyga Kaufmann, Margaret Rukstalis, Freda Patterson, Kenneth Perkins, Janet Audrain-McGovern, Neal Benowitz, Individualizing Nicotine Replacement Therapy for the Treatment of Tobacco Dependence: A Randomized Trial Annals of Internal Medicine. ,vol. 140, pp. 426- 433 ,(2004) , 10.7326/0003-4819-140-6-200403160-00009
T Abelin, P Müller, A Buehler, K Vesanen, P.R Imhof, Controlled trial of transdermal nicotine patch in tobacco withdrawal. The Lancet. ,vol. 333, pp. 7- 10 ,(1989) , 10.1016/S0140-6736(89)91671-1